Patent Assignment
Reel/Frame 013182/0220
Assignment of Assignor's Interest
Recorded: 2002-08-13
Pages: 8
Assignors
PAVCO, PAMELA
Executed: 2002-06-27
MCSWIGGEN, JAMES
Executed: 2002-07-01
STINCHCOMB, DAN
Executed: 2002-06-21
Assignee
RIBOZYME PHARMACEUTICALS, INC.
2950 WILDERNESS PLACE, BOULDER, COLORADO, 80301
Covered Property
(1)
Enzymatic Nucleic Acid-Mediated Treatment of Ocular Diseases or Conditions Related to Levels of Vascular Endothelial Growth Factor Receptor (Vegf-R)
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 13, 2002
From: ESCOBEDO, JAIME
To: CHIRON CORPORATION, INC.
Reel/Frame 013182/0308 →
Change of Name
Mar 21, 2005
From: RIBOZYME PHARMACEUTICALS, INC.
To: SIRNA THERAPEUTICS, CIN
Reel/Frame 016378/0443 →
Corrective Name Change to Correct Assignee's Name Previously Recorded at Reel 016378 Frame 0443.
Oct 5, 2005
From: RIBOZYME PHARMACEUTICALS, INC.
To: SIRNA THERAPEUTICS, INC.
Reel/Frame 016854/0262 →